Humana (NYSE:HUM) Now Covered by Analysts at Sanford C. Bernstein

Equities research analysts at Sanford C. Bernstein assumed coverage on shares of Humana (NYSE:HUM) in a research note issued to investors on Thursday, The Fly reports. The brokerage set a “market perform” rating on the insurance provider’s stock.

A number of other brokerages also recently issued reports on HUM. Deutsche Bank increased their price objective on Humana from $397.00 to $431.00 and gave the stock a “hold” rating in a research report on Thursday, September 10th. Mizuho raised their price target on Humana from $420.00 to $462.00 and gave the company a “buy” rating in a report on Friday, August 7th. Cantor Fitzgerald boosted their price objective on Humana from $405.00 to $410.00 in a report on Wednesday, June 17th. SVB Leerink upped their price objective on shares of Humana from $465.00 to $496.00 and gave the stock an “outperform” rating in a research report on Thursday, August 6th. Finally, Piper Sandler lifted their target price on shares of Humana from $473.00 to $495.00 and gave the company an “overweight” rating in a research report on Thursday. Eight investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Humana presently has an average rating of “Buy” and an average price target of $434.62.

Shares of NYSE HUM traded up $1.47 during mid-day trading on Thursday, hitting $415.36. The company had a trading volume of 541,294 shares, compared to its average volume of 1,093,187. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.42. Humana has a 1 year low of $208.25 and a 1 year high of $431.12. The company has a market capitalization of $54.75 billion, a price-to-earnings ratio of 15.80, a P/E/G ratio of 1.72 and a beta of 0.89. The stock’s 50-day moving average price is $407.37 and its 200-day moving average price is $377.26.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $12.56 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $10.34 by $2.22. Humana had a return on equity of 26.70% and a net margin of 4.96%. The firm had revenue of $19.08 billion for the quarter, compared to analysts’ expectations of $18.66 billion. During the same period in the prior year, the business posted $6.05 earnings per share. The company’s revenue was up 17.5% on a year-over-year basis. As a group, equities research analysts forecast that Humana will post 19.02 earnings per share for the current year.

Institutional investors have recently made changes to their positions in the stock. Global Retirement Partners LLC lifted its stake in Humana by 34.2% in the second quarter. Global Retirement Partners LLC now owns 106 shares of the insurance provider’s stock worth $41,000 after acquiring an additional 27 shares during the period. CWM LLC raised its holdings in Humana by 19.4% in the 2nd quarter. CWM LLC now owns 166 shares of the insurance provider’s stock worth $64,000 after purchasing an additional 27 shares in the last quarter. Blair William & Co. IL raised its holdings in Humana by 0.8% in the 2nd quarter. Blair William & Co. IL now owns 3,751 shares of the insurance provider’s stock worth $1,454,000 after purchasing an additional 29 shares in the last quarter. Harbor Investment Advisory LLC lifted its position in shares of Humana by 41.3% in the 2nd quarter. Harbor Investment Advisory LLC now owns 106 shares of the insurance provider’s stock worth $41,000 after purchasing an additional 31 shares during the period. Finally, Harwood Advisory Group LLC boosted its stake in shares of Humana by 5.9% during the 2nd quarter. Harwood Advisory Group LLC now owns 579 shares of the insurance provider’s stock valued at $224,000 after purchasing an additional 32 shares in the last quarter. Institutional investors own 92.43% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Read More: Average Daily Trade Volume – ADTV

The Fly

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.